These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25633529)

  • 1. 18F-fluorodeoxyglucose uptake level-based lymph node staging in oropharyngeal squamous cell cancer--role of molecular marker expression on diagnostic outcome.
    Sadick M; Weiss C; Piniol R; Frey S; Hoermann K; Schoenberg SO; Sadick H
    Oncol Res Treat; 2015; 38(1-2):16-22. PubMed ID: 25633529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
    Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
    J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
    Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
    PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
    Fayad H; Le Pogam A; Lamare F; Fernandez P; Pradier O; Valette G; Visvikis D; Cheze Le Rest C
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):319-28. PubMed ID: 25265252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.
    Yu W; Fu XL; Zhang YJ; Xiang JQ; Shen L; Chang JY
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e759-65. PubMed ID: 21470788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
    Hitier-Berthault M; Ansquer C; Branchereau J; Renaudin K; Bodere F; Bouchot O; Rigaud J
    Int J Urol; 2013 Aug; 20(8):788-96. PubMed ID: 23279605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.
    Matsubara R; Kawano S; Chikui T; Kiyosue T; Goto Y; Hirano M; Jinno T; Nagata T; Oobu K; Abe K; Nakamura S
    Acad Radiol; 2012 Jun; 19(6):708-17. PubMed ID: 22484437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
    Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
    Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.
    Dräger DL; Heuschkel M; Protzel C; Erbersdobler A; Krause BJ; Hakenberg OW; Schwarzenböck SM
    Nuklearmedizin; 2018 Feb; 57(1):26-30. PubMed ID: 29536497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
    Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
    Clin Otolaryngol; 2014 Dec; 39(6):338-44. PubMed ID: 25102759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
    Rouanne M; Girma A; Neuzillet Y; Vilain D; Radulescu C; Letang N; Yonneau L; Hervé JM; Botto H; Le Stanc E; Lebret T
    Eur J Surg Oncol; 2014 Dec; 40(12):1724-30. PubMed ID: 25242381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET/MR for lymph node staging in head and neck cancer.
    Platzek I; Beuthien-Baumann B; Schneider M; Gudziol V; Kitzler HH; Maus J; Schramm G; Popp M; Laniado M; Kotzerke J; van den Hoff J
    Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
    Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
    J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
    Peng Z; Liu Q; Li M; Han M; Yao S; Liu Q
    Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.